Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thanks @Dave
Will be glad to see the back of this year, here's to a better 2022
Meanwhile, once they have the data sets it all needs collating. Also, lets face it, for Shareholders it needs putting into layman's terms. I'm fairly relaxed, they are into so many verticals with this its incredible. Some are potentially explosive.
I think if they can issue an update on the Asthma and the Pancreatic trials that are due in days, this could be the trigger for II buying and bring greater awareness to new retail investors, whilst giving existing investors further positive reassurance of the continuing progress. Would also give the media and all the share publications something positive to report on.
I notice we closed up on the Nasdaq just short of 9% tonight so you never know that could kick start us here? Personally i think some of the issue we have regarding the share price is just simply down to lack of awareness . On this AIM market which is at best a dam Casino at times, investors are chasing all kinds of cr@p without knowing anything about what they are buying, just following trends and graphs. There are companies with next to nothing behind them getting all kinds of investment volume, we just need the break here to get noticed.
At 4D as i see it, this is a phenomenal business, massive amounts of IP, the research and development is simply incredible.
From my own research, I really believe this is the future. If you asked the average man in the street what live biotherapeutic products (LBP) are they wouldn't have a dam clue BUT, in time i think they could end up being as common place as an antibiotic.
Anyhow, will shut up now, lol. See how events unfold. When i tell other investors about LBP and they look at me blank, i just point them to the 2min video on the 4D website, it speaks volumes:-
https://www.4dpharmaplc.com/en
Our day in the sun will come here, I'm sure. Just a waiting game for now, GLA
Enjoy the time off Porky :)
LOL
Impatient but a lot are, some updates now would be great
That's why the shorter's and MMs do so well at this time of year.
As long as its quality when it arrives that's good enough for me
Take care
I think I am getting concerned or is it impatient. I honestly do not know which.